Atlas Trials

Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Clinical trial NCT04075110 · COMPLETED

Trial details

NCT number
NCT04075110
Sponsor
Sadat City University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Obesity; Endocrine; Diabetes Type 2
Start date
2019-07-01
Primary completion
2022-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.